AstraZeneca plc is a British-Swedish multinational pharmaceutical and biologics company headquartered in London, United Kingdom. It is the world's seventh-largest pharmaceutical company measured by 2012 prescription drug sales (after Pfizer, Sanofi, Novartis, Merck & Co., Roche and GlaxoSmithKline) and has operations in over 100 countries.
(Spun off from Imperial Chemical Industries 1993)
Salick Health Care
Ishihara Sangyo Kaisha
(US fungicide operations, Acq 1997)
Cambridge Antibody Technology
Guangdong BeiKang Pharmaceutical Company
(Acq 2012 jointly with Bristol-Myers Squibb )
(share of global diabetes alliance, Acq 2013)
(Spun off 2015)
– Infectious diseases
– Respiratory and inflammatory diseases
In April 2015 AstraZeneca's drug tremelimumab was approved as an orphan drug for the treatment of mesothelioma in the United States. It awaits FDA approval prior to marketing.